Circio Holding ASA: First half 2023 results
Oslo, Norway, 24 August 2023 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing novel circular RNA and immunotherapy medicines, today announces its first half 2023 results. Members of Circio’s executive management team will give an online presentation to investors, analysts and the press at 10:00 CET today (details below).FIRST HALF 2023 HIGHLIGHTS Corporate · The company was rebranded as Circio, an innovator in next generation circular RNA therapeutics · A convertible bond facility with Atlas Special Opportunities was established, securing up to NOK 300